Table 3 Cumulative 0 to 30 and 31 to 365 day mortality and corresponding crude and adjusted mortality rate ratios (MRR)
From: Preadmission statin use and one-year mortality among patients in intensive care - A cohort study
| Â | Number (n) | Mortality (%) | Crude MRR (95% CI) | Adjusted MRR (95% CI)* |
|---|---|---|---|---|
0 to 30 days | Â | Â | Â | Â |
Statin use | 1882 | 22.1% | 0.85 (0.76-0.96) | 0.76 (0.68-0.85) |
No statin use | 11,313 | 25.0% | 1 -- | 1 -- |
0 to 365 days | Â | Â | Â | Â |
Statin use | 1882 | 36.4% | 0.84 (0.76-0.93) | 0.78 (0.71-0.84) |
No statin use | 11,313 | 39.9% | 1 -- | 1 -- |